Search Results 701-710 of 13082 for risksas
HER2-positive breast cancer: What is it? Infographic: Breast Cancer Risk · Lumpectomy · Modified radical mastectomy · Nipple changes · Paulas story A team ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
Tipifarnib will be administered until disease progression then followed approximately every 12 weeks for survival until either death or 12 months after accrual ...
About this study. The Zenith® TX2® Low Profile TAA Endovascular Graft study is a clinical trial approved by US FDA to evaluate the safety and effectiveness ...
Has anyone used Mepitel ? 30 Replies Thu, Jun 19, 2025. elsie37 · The math of invasive breast cancer risk for LCIS.
The primary purpose of this study is to assess progression-free survival of men who have oligometastatic prostate cancer after randomization to stereotactic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.